Peter Bacher

Differences in Glucose Tolerance Between Fixed-Dose Antihypertensive Drug Combinations in People With Metabolic Syndrome

George L. Bakris, Mark E. Molitch, Ann C. Hewkin et al. · Diabetes Care · 2006 · 185 citations

Verapamil-sustained release–based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: An INternational VErapamil SR-Trandolapril (INVEST) substudy

Sripal Bangalore, Franz H. Messerli, Jerome D. Cohen et al. · American Heart Journal · 2008 · 54 citations

Thrombosis, Cardiovascular Disease, Prior Myocardial Infarction +8

Dose-finding and pharmacokinetic profiles of prophylactic doses of a low molecular weight heparin (reviparin–sodium) in pediatric patients

Patricia Massicotte, Jim A. Julian, Velma Marzinotto et al. · Thrombosis Research · 2003 · 48 citations

Drug Safety, Therapeutic Drug Monitoring, Pharmacokinetic Modeling +11

36-Month Treatment Experience of Two Doses of Leuprolide Acetate 3-Month Depot for Children With Central Precocious Puberty

Peter A. Lee, Karen O. Klein, Nelly Mauras et al. · The Journal of Clinical Endocrinology & Metabolism · 2014 · 42 citations · Full text

Differential effects of clivarin and heparin in patients undergoing hip and knee surgery for the generation of anti-heparin-platelet factor 4 antibodies

Sarfraz Ahmad, Sylvia Haas, Debra A. Hoppensteadt et al. · Thrombosis Research · 2002 · 34 citations

Thrombopoiesis, Thrombosis, Differential Effects +11